share_log

Fulcrum Therapeutics | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement

SEC announcement ·  May 9, 2022 16:49
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more